Shares of SmartKem slid roughly 5% to the mid-$0.20s after the micro-cap organic semiconductor company's June 23 annual meeting delivered two shareholder approvals that spooked the market: a massive expansion of authorized shares to 5 billion and board authority to execute a reverse stock split. SmartKem's 5-Billion-Share Blank Check: Survival Tactic or a Slow Squeeze on Shareholders?
Shares of SmartKem slid roughly 5% to the mid-$0.20s after shareholders at the June 23 annual meeting approved a sweeping overhaul of the company's capital structure, handing the board authority to issue up to 5 billion common shares — up from 300 million — and to execute reverse stock splits. For a company with a market value of barely $10 million and trailing twelve-month revenue of just $697,000, the moves signal desperation as much as strategy.
• A 16-Fold Jump in Authorized Shares Creates Enormous Dilution Risk. The approved changes include increasing authorized common stock from 300 million to 5 billion shares, expanding the employee equity incentive plan, and granting the board discretion to implement up to two reverse stock splits.
The company also won approval to issue shares below Nasdaq's minimum price in excess of 19.99% of outstanding shares under an equity line of credit and upon conversion of Series A preferred stock and related warrants. For current holders of SMTK's roughly 6.13 million shares outstanding, this creates a vast pool of potential new stock that could crush each share's slice of the company. The share count has already increased by 105% in the past year.
• The Real Driver Is a Fight to Stay on Nasdaq. In February 2026, Nasdaq staff notified SmartKem that, due to continued non-compliance with the minimum stockholders' equity rule, it had determined to delist the company's securities.
In response, SmartKem raised about $9.1 million through Series A preferred stock and warrants in March, partly by exchanging old debt — financings designed to strengthen stockholders' equity after Nasdaq warned of a potential delisting for failing the $2.5 million equity threshold. The share authorization is the ammunition that makes those deals work.
• The Business Underneath Is Barely Producing Revenue. SmartKem generated just $697,000 in trailing twelve-month revenue against a net loss of $10.5 million.
The company holds only $881,000 in cash against $650,000 in debt.
Its current ratio — a measure of ability to cover short-term bills — sits at a perilous 0.25. Without rapid new revenue or further fundraising, the authorized shares become the company's primary financial tool.
• A Reverse Split Would Be History Repeating. SmartKem already executed a 1-for-35 reverse split in September 2023. Another consolidation would artificially boost the per-share price to meet Nasdaq's $1 minimum bid requirement, but historically such moves in micro-caps simply reset the clock on a downward slide. The Series A preferred stock ranks senior to common shares and carries a punishing 15% default dividend rate , meaning preferred investors get paid first if things unravel — common shareholders are last in line.